- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05635175
Effectiveness of a Hip Abductor Training in Women With Stress Urinary Incontinence (PROTOGLUT)
Urinary incontinence (UI) is estimated to affect 25% à 45 % women all over the world. UI is associated with a poor Quality of life, with a strong level of certainty. Stress urinary incontinence (SUI) is the second more prevalent type of UI . First-line treatment for SUI is conservative, non-drug and non-surgical treatment. Among these techniques, physiotherapist-supervised pelvic floor muscle (PFM) training (PFMT) as a first-line treatment; however, only half of women with SUI are cured with PFMT.
Brain imaging shows that PFMs (involved in continence mechanisms) and gluteal muscles can activate the same cortical region. This synergy is found if the gluteal muscles are voluntarily activated, but not if the PFMs are volontary activated alone . In women, hip abductor physiotherapy is a common practice which has already been the subject of a very extensive literature and has largely shown its effectiveness in the quality of lumbo-pelvic control, balance, quality of life and risk of fall prevention. This rehabilitation is based on exercises that induce solicitation of the hip abductors by synergistic reflex activation during a range of well-known exercises. Recent work has shown the effect of hip abductors on the activation of the PFMs . Until today, there is no literature evaluating the effectiveness of a hip abductors training program without associated voluntary contraction of the PFMs (PPM) on UI. The hypothesis of this work will be to demonstrate that a complementary training focused on the hip abductor, complementary to concomitant PFMT, would benefit from a more significant improvement in continence, and also in physical abilities and quality of life. Because balance seems involved in UI, we therefore propose to to observe the effects on the frontal balance of the pelvis. As the investigators have already done in previous studies, to identifying factors that predict the success of our interventions, investiagtors have planned to evaluate the observance and adherence of our patients .Complementary, the investigators planned to evaluate the effect of both intervention on pelvic floor muscles and hip abductors strength and endurance, pelvic organ prolapse symptoms and quality of life. For this objective, the investigators intend to compare two randomized parallel groups: Group A follow a 12 sessions supervised PFMT + home based PFMs exercices. Group B follow a 12 sessions supervised PFMT + home based hip abductor exercices.
Study Overview
Status
Conditions
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Benoit STEENSTRUP, physiotherapist
- Phone Number: +33 2 32 88 89 90
- Email: benoit.stennstrup@chu-rouen.fr
Study Contact Backup
- Name: Déborah LEBEDIEFF
- Phone Number: +33 2 32 88 89 90
- Email: deborah.lebedieff@chu-rouen.fr
Study Locations
-
-
-
Caen, France
- Recruiting
- Pôle santé de la Grace Dieu
-
Contact:
- Guillaume GALLIOU, physiotherapist
- Phone Number: + 33 2 31 83 48 02
- Email: guillaume.galliou@gmail.com
-
Rouen, France
- Recruiting
- CHU Rouen
-
Contact:
- Benoit STEENSTRUP, physiotherapist
- Phone Number: + 33 2 32 88 81 55
- Email: benoit.steenstrup@chu-rouen.fr
-
Saint-Étienne-du-Rouvray, France
- Recruiting
- Médipôle du Rouvray
-
Contact:
- Claire BRETON, physiotherapist
- Phone Number: + 33 2 35 66 06 38
- Email: clairebreton.kine@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Women ≥ 18 ans
- patient with urinary incontinence according to the ICS criteria [3]
- having received a prescription for perineal rehabilitation
- affiliated to french health care insurance
- Patient having read and understood the information letter and signed the consent form
- Effective contraception in women of childbearing age (negative urine pregnancy test). For postmenopausal women, a confirmatory diagnosis must be obtained (amenorrhea for at least 12 months before the inclusion visit)
Exclusion Criteria:
- Bladder pathologies (cyst, tumour, interstitial cystitis)
- Neurological pathologies (multiple sclerosis, Parkinson's desease, etc.)
- Pregnant or parturient or breastfeeding woman or absence of proven contraception
- Person deprived of liberty by administrative or judicial decision or a person placed under the safeguard of justice, or guardianship or curatorship
- Physical inability to perform hip abductors exercises (unable to walk or stand independently)
- Women having scheduled continence surgery before the end of physiotherapy sessions at the time of randomization
- Women having at least one of the continence-specific anticholinergic treatments prescribed before the end of the physiotherapy sessions at the time of randomization
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: physiotherapist-supervised pelvic floor muscle training
physiotherapist-supervised pelvic floor muscle (PFM) training (PFMT) and self training PFMT
|
Standard pelvic floor muscle training
Standard pelvic floor muscle training self training
|
|
Experimental: hip abductors self training program
physiotherapist-supervised pelvic floor muscle (PFM) training (PFMT) and self training hip abductors self training program
|
Standard pelvic floor muscle training
hip abductors self training program during 7 to 10 weeks associate with a PFMT
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The difference in the number of leaks per week observed after the end of treatment between the two arms at the last physiotherapy session.
Time Frame: 10 weeks
|
This number of leaks per week will be recorded using question 3 of the International Consultation on Incontinence Questionnaire (ICIQ-SF).
|
10 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Measurement in centimeters of the offset in the frontal plane of the postero-superior iliac spines during a one leg stance
Time Frame: 10 weeks
|
10 weeks
|
|
|
Average of the measurement in Newton of the force of the hip abductors during a maximum manual resistance test repeated 3 times using a dynamometer
Time Frame: 10 weeks
|
10 weeks
|
|
|
Average of measurement in seconds of the hip abductors resistance during a manual resistance test repeated 10 times
Time Frame: 10 weeks
|
10 weeks
|
|
|
Measurement rated from 1 to 5 of the strength of PFMs according to the "Modified Oxford Grading Scale" testing
Time Frame: 10 weeks
|
10 weeks
|
|
|
Overall score and sub-scores of urinary symptoms from the international consultation on incontinence questionnaire
Time Frame: 10 weeks
|
min: 0 : better outcome max : 21 worse outcome
|
10 weeks
|
|
Overall score and sub-scores of urinary symptoms of the Prolape quality of life questionnaire
Time Frame: 10 weeks
|
10 weeks
|
|
|
Short Form-36 Quality of Life overall score and subscores
Time Frame: 10 weeks
|
10 weeks
|
|
|
Overall score and sub-scores of physical inactivity and physical abilities from the Ricci & Gagnon questionnaire
Time Frame: 10 weeks
|
10 weeks
|
|
|
Overall score and sub-scores of the therapeutic observance and adherence questionnaire (only at the end of treatment)
Time Frame: 10 weeks
|
10 weeks
|
|
|
Patient Global Impression of Improvement (PGI-I) questionnaire score (only at end of treatment)
Time Frame: 10 weeks
|
10 weeks
|
|
|
Overall score and sub-scores of urinary symptoms from the international consultation on incontinence questionnaire questionnaire
Time Frame: through study completion, an average of 6 month
|
through study completion, an average of 6 month
|
|
|
Overall score and sub-scores of urinary symptoms of the Prolapsus Quality of Life questionnaire 3. SF-36 Quality of Life overall score and subscores
Time Frame: throught study completion, an average of 6 month
|
throught study completion, an average of 6 month
|
|
|
Overall score and sub-scores of physical inactivity and physical abilities from the Ricci & Gagnon questionnaire
Time Frame: throught study completion, an average of 6 month
|
throught study completion, an average of 6 month
|
|
|
Score du questionnaire Patient Global Impression of Improvement (PGI-I)
Time Frame: throught study completion, an average of 6 month
|
min: 1 better outcome max : 7 worse outcome
|
throught study completion, an average of 6 month
|
Collaborators and Investigators
Sponsor
Collaborators
Publications and helpful links
General Publications
- Stewart WF, Hirsh AG, Kirchner HL, Clarke DN, Litchtenfeld MJ, Minassian VA. Urinary incontinence incidence: quantitative meta-analysis of factors that explain variation. J Urol. 2014 Apr;191(4):996-1002. doi: 10.1016/j.juro.2013.10.050. Epub 2013 Oct 16.
- Ebbesen MH, Hunskaar S, Rortveit G, Hannestad YS. Prevalence, incidence and remission of urinary incontinence in women: longitudinal data from the Norwegian HUNT study (EPINCONT). BMC Urol. 2013 May 30;13:27. doi: 10.1186/1471-2490-13-27.
- Pizzol D, Demurtas J, Celotto S, Maggi S, Smith L, Angiolelli G, Trott M, Yang L, Veronese N. Urinary incontinence and quality of life: a systematic review and meta-analysis. Aging Clin Exp Res. 2021 Jan;33(1):25-35. doi: 10.1007/s40520-020-01712-y. Epub 2020 Sep 22.
- Hay-Smith EJC, Starzec-Proserpio M, Moller B, Aldabe D, Cacciari L, Pitangui ACR, Vesentini G, Woodley SJ, Dumoulin C, Frawley HC, Jorge CH, Morin M, Wallace SA, Weatherall M. Comparisons of approaches to pelvic floor muscle training for urinary incontinence in women. Cochrane Database Syst Rev. 2024 Dec 20;12(12):CD009508. doi: 10.1002/14651858.CD009508.pub2.
Helpful Links
- Steenstrup B, M. Pavy Lebrun, Aigueperse N, Quemener N, Cheveau S, Confalonieri C, Totte F. Efficacité d'une rééducation sensori-motrice posturale réflexe sur l'incontinence urinaire et l'urgenturie chez la femme. Kinesith Rev. 2019;19(206):12-18
- Steenstrup B, Behague L, Quehen M. Rééducation posturale avec le jeu virtuel Wii ® en pelvi périnéologie: pourquoi pas? Kinésith Rev. 2015;15(160):45-50
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2020/0176/HP
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Women With Stress Urinary Incontinence
-
Far Eastern Memorial HospitalRecruitingWomen With Stress Urinary IncontinenceTaiwan
-
Hospital General de Agudos J. M. PennaNot yet recruitingPelvic Organ Prolapse Vaginal Surgery | Stress Urinary Incontinence in WomenArgentina
-
Shanghai Yueyang Integrated Medicine HospitalCompletedStress Urinary Incontinence in WomenChina
-
American Medical SystemsUnknownStress Urinary Incontinence in WomenUnited States
-
Comenius UniversityCompletedStress Urinary Incontinence in WomenSlovakia
-
Lahore University of Biological and Applied SciencesActive, not recruitingStress Urinary Incontinence in Women | Stress Urinary Incontinence (SUI)Pakistan
-
National Taiwan University HospitalCompletedUrodynamic Stress Incontinence in Severe Cystocele Women
-
Hanoi Medical UniversityNot yet recruitingPostmenopausal Women | Stress Urinary Incontinence (SUI)
-
Vanderbilt University Medical CenterEnrolling by invitationStress Urinary Incontinence in WomenUnited States
-
TBF Genie TissulaireNot yet recruitingStress Urinary Incontinence in WomenFrance
Clinical Trials on Standard pelvic floor muscle training
-
The University of Hong KongRuijin HospitalRecruitingProstate Cancer (Post Prostatectomy)Hong Kong, China
-
Izmir University of EconomicsDokuz Eylul UniversityRecruitingPelvic Floor Muscle Training | Healthy Adult Women | Pelvic Floor Muscle ExerciseTurkey (Türkiye)
-
Tri-Service General HospitalCompletedProstate Cancer | Radical ProstatectomyTaiwan
-
Hacettepe UniversityCompletedStress Urinary IncontinenceTurkey
-
Herlev HospitalCompletedUrinary Stress IncontinenceDenmark
-
Tanta UniversityRecruitingPremature Ejaculation | Male Sexual Dysfunction | Lifelong Premature EjaculationEgypt
-
Trakya UniversityCompletedStress Urinary Incontinence | Pelvic Floor Muscle Weakness
-
Mehmet IncebıyikCompletedPelvic Floor Dysfunction | Labor Complications | Pelvic Floor Muscle Training | Perineal TraumaTurkey (Türkiye)
-
Mansoura Universityurology and nephrology center mansoura universityRecruiting
-
Norwegian School of Sport SciencesTerminatedUrinary Incontinence | Stress Urinary IncontinenceNorway